Diabetic Foot Ulcers Treatment Market by Ulcer Type, Product Type, End User and by Geography - Global Trends and Forecast to 2025

Diabetic Foot Ulcers Treatment Market by Ulcer Type, Product Type, End User and by Geography - Global Trends and Forecast to 2025

Diabetic foot ulcers is a common disease observed in diabetic patients. According to facts presented in fact sheet 2017, Center for Disease and Prevention, among the total diabetic population, 60%–80% suffers from foot ulcers. New and innovative treatments in wound dressings and therapy devices is expected to augment the diabetic foot ulcers treatment market growth. Since there are less availability of products to treat diabetic foot ulcers by device, provides a great opportunity for key players as well as new entrants to enter the diabetic foot ulcers treatment market. Furthermore, Negative pressure wound therapy devices essential for the management of diabetic foot ulcers, as also expected to favor the growth of diabetic foot ulcers treatment market.
Market Dynamics
Diabetic foot ulcers treatment market is mainly driven by increasing prevalence of diabetes. According to World Health Organization, it was estimated that 422 million adults were suffering from diabetes, in 2014 globally. Furthermore, according to National Diabetes Statistics Report 2017, 30.3 million people in the U.S. have been estimated to have diabetes. This is expected to favor growth of the diabetic foot ulcers treatment market.
Furthermore, according to the data published by Agency for Healthcare Research & Quality (AHRQ) in October 2014, over 2.5 million individuals in the U.S. develop pressure ulcers annually, which costs the U.S. health care system around US$ 9.1 billion to US$ 11.6 billion per year
Increasing number of product launches and innovative therapies are also expected to drive the diabetic foot ulcers treatment market growth. For instance, in December 2017, FDA approved shockwave therapy by Dermapace for diabetic foot ulcers treatment. The FDA also approved a spray, Granulox by infirst Healthcare Ltd, in November 2017, for the treatment of diabetic foot ulcers.  
Key features of the study:

This report provides an in-depth analysis of global diabetic foot ulcers treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global diabetic foot ulcers treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include 3M Healthcare Ltd, Coloplast A/S, B.Braun Melsungen AG, Acelity L.P. Inc., Smith & Nephew Plc., Medtronic Plc, and ConvaTec Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global diabetic foot ulcers treatment market report caters to various stakeholders in this industry including investors, suppliers, diabetic foot ulcers treatment manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the diabetic foot ulcers treatment market

Detailed Segmentation:

Global Diabetic Foot Ulcers Treatment Market, By Ulcers:

Neuropathic Ulcers
Neuro-Ischemic Ulcers

Global Diabetic Foot Ulcers Treatment Market, By Product Type:

Wound Care Dressings

Foam Dressing
Hydrocolloid Dressing
Hydrogel Dressing
Alginate Dressing
Other Dressing

Biologics

Growth factors
Skin Graft and Skin Substitutes

Wound Care Therapy Devices

Negative Pressure Wound Devices
Hyperbaric Oxygen Therapy
Other Wound Care Therapy Devices

Others 

Global Diabetic Foot Ulcers Treatment Market, By End User:

Hospital
Clinics
Ambulatory Surgical Center
Homecare Setting

Global Diabetic Foot Ulcers Treatment Market, By Geography:

North America

By Ulcers:

Neuropathic Ulcers
Neuro-Ischemic Ulcers

By Product Type:

Wound Care Dressings

Foam Dressing
Hydrocolloid Dressing
Hydrogel Dressing
Alginate Dressing
Other Dressing

Biologics

Growth factors
Skin Graft and Skin Substitutes

Wound Care Therapy Devices

Negative Pressure Wound Devices
Hyperbaric Oxygen Therapy
Other Wound Care Therapy Devices
Others

By End User

Hospital
Clinics
Ambulatory Surgical Center
Homecare Setting

By Country

U.S.
Canada

Europe

By Ulcers:

Neuropathic Ulcers
Neuro-Ischemic Ulcers

By Product Type:

Wound Care Dressings

Foam Dressing
Hydrocolloid Dressing
Hydrogel Dressing
Alginate Dressing
Other Dressing

Biologics

Growth factors
Skin Graft and Skin Substitutes

Wound Care Therapy Devices

Negative Pressure Wound Devices
Hyperbaric Oxygen Therapy
Other Wound Care Therapy Devices
Others

By End User

Hospital
Clinics
Ambulatory Surgical Center
Homecare Setting

By Country

U.K.
Germany
Italy
France
Russia
Spain
Rest of Europe

Asia Pacific

By Ulcers:

Neuropathic Ulcers
Neuro-Ischemic Ulcers

By Product Type:

Wound Care Dressings

Foam Dressing
Hydrocolloid Dressing
Hydrogel Dressing
Alginate Dressing
Other Dressing

Biologics

Growth factors
Skin Graft and Skin Substitutes

Wound Care Therapy Devices

Negative Pressure Wound Devices
Hyperbaric Oxygen Therapy
Other Wound Care Therapy Devices
Others

By End User

Hospital
Clinics
Ambulatory Surgical Center
Homecare Setting

By Country

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Latin America

By Ulcers:

Neuropathic Ulcers
Neuro-Ischemic Ulcers

By Product Type:

Wound Care Dressings

Foam Dressing
Hydrocolloid Dressing
Hydrogel Dressing
Alginate Dressing
Other Dressing

Biologics

Growth factors
Skin Graft and Skin Substitutes

Wound Care Therapy Devices

Negative Pressure Wound Devices
Hyperbaric Oxygen Therapy
Other Wound Care Therapy Devices
Others

By End User

Hospital
Clinics
Ambulatory Surgical Center
Homecare Setting

By Country

Brazil
Mexico
Rest of Latin America

Middle East

By Ulcers:

Neuropathic Ulcers
Neuro-Ischemic Ulcers

By Product Type:

Wound Care Dressings

Foam Dressing
Hydrocolloid Dressing
Hydrogel Dressing
Alginate Dressing
Other Dressing

Biologics

Growth factors
Skin Graft and Skin Substitutes

Wound Care Therapy Devices

Negative Pressure Wound Devices
Hyperbaric Oxygen Therapy
Other Wound Care Therapy Devices
Others

By End User

Hospital
Clinics
Ambulatory Surgical Center
Homecare Setting

By Country

GCC
Israel
Rest of Middle East

Africa

By Ulcers:

Neuropathic Ulcers
Neuro-Ischemic Ulcers

By Product Type:

Wound Care Dressings

Foam Dressing
Hydrocolloid Dressing
Hydrogel Dressing
Alginate Dressing
Other Dressing

Biologics

Growth factors
Skin Graft and Skin Substitutes

Wound Care Therapy Devices

Negative Pressure Wound Devices
Hyperbaric Oxygen Therapy
Other Wound Care Therapy Devices
Others

By End User

Hospital
Clinics
Ambulatory Surgical Center
Homecare Setting

By Country

North Africa
Central Africa
South Africa

Company Profiles

3M Healthcare Ltd*

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Future Plans

Coloplast A/S
B.Braun Melsungen AG
Medtronic plc.
Acelity L.P. Inc.
Smith & Nephew Plc.
ConvaTec Inc.

Mölnlycke Health Care

 “*” marked represents similar segmentation in other categories in the respective section.